Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
Renguo Guan, Jie Mei, Wen‐Ping Lin, Min Deng, Shaohua Li, Rong Guo
Topics & Concepts
MedicineHepatologyHepatocellular carcinomaInternal medicineColorectal surgerySurgical oncologyImmunotherapyAdverse effectOncologyGastroenterologyCarcinomaAbdominal surgeryCancerHepatocellular Carcinoma Treatment and PrognosisInflammatory Biomarkers in Disease PrognosisCancer Immunotherapy and Biomarkers